We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $697M
1-Year Est. Return 79.73%
This Fund
S&P 500
This Quarter Est. Return
+15.35%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$370M
AUM Growth
+$95.8M
Cap. Flow
+$73.9M
Cap. Flow %
19.94%
Top 10 Hldgs %
36.28%
Holding
91
New
23
Increased
27
Reduced
13
Closed
22

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$24.7M
2
CVS icon
CVS Health
CVS
+$13.7M
3
GSK icon
GSK
GSK
+$10.5M
4
GILD icon
Gilead Sciences
GILD
+$9.94M
5
GMED icon
Globus Medical
GMED
+$9.18M

Top Sells

Rank Stock Value
1
COR icon
Cencora
COR
+$9.96M
2
CI icon
Cigna
CI
+$9.92M
3
CAH icon
Cardinal Health
CAH
+$9.32M
4
CELG
Celgene Corp
CELG
+$6.56M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$6.31M

Sector Composition

Rank Sector Weight
1 Healthcare 80.51%
2 Industrials 1.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRTX icon
26
Vertex Pharmaceuticals
VRTX
$121B
$5.19M 1.4%
+28,232
New +$5.21M
FOMX
27
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$4.86M 1.31%
1,295,669
+144,159
+13% +$540K
ALXN
28
DELISTED
Alexion Pharmaceuticals
ALXN
$4.79M 1.29%
35,421
+18,421
+108% +$2.29M
BNGO icon
29
Bionano Genomics
BNGO
$12.3M
$4.63M 1.25%
2,564
+170
+7% +$445K
STRO icon
30
Sutro Biopharma
STRO
$401M
$4.54M 1.23%
39,880
+11,689
+41% +$1.22M
SNN icon
31
Smith & Nephew
SNN
$13.3B
$4.42M 1.19%
110,327
+8,164
+8% +$314K
EGRX
32
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$4.28M 1.15%
+84,695
New +$3.77M
SYNH
33
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$4.24M 1.14%
+81,899
New +$3.97M
MRTX
34
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$4.16M 1.12%
+56,800
New +$3.86M
RIGL icon
35
Rigel Pharmaceuticals
RIGL
$681M
$4.14M 1.12%
160,927
-57,128
-26% -$1.31M
SRCL
36
DELISTED
Stericycle Inc
SRCL
$4.08M 1.1%
+75,000
New +$3.4M
PETS icon
37
PetMed Express
PETS
$41.7M
$4.06M 1.1%
+178,151
New +$4.02M
RVNC
38
DELISTED
Revance Therapeutics, Inc.
RVNC
$4.01M 1.08%
254,581
+86,857
+52% +$1.51M
UTHR icon
39
United Therapeutics
UTHR
$25.8B
$3.95M 1.07%
33,655
+3,655
+12% +$426K
VAR
40
PUT
DELISTED
Varian Medical Systems, Inc.
VAR
$3.91M 1.06%
+27,600
New +$3.62M
ZBH icon
41
Zimmer Biomet
ZBH
$18.2B
$3.83M 1.03%
30,900
-5,298
-15% -$602K
UNH icon
42
UnitedHealth
UNH
$376B
$3.81M 1.03%
15,407
+1,200
+8% +$306K
SYK icon
43
PUT
Stryker
SYK
$125B
$3.79M 1.02%
+19,200
New +$3.46M
IDXX icon
44
PUT
Idexx Laboratories
IDXX
$44.1B
$3.78M 1.02%
+16,900
New +$3.49M
GYRE icon
45
Gyre Therapeutics
GYRE
$641M
$3.68M 0.99%
60,574
+21,691
+56% +$1.39M
PEN icon
46
PUT
Penumbra
PEN
$12.7B
$3.53M 0.95%
24,000
-10,000
-29% -$1.43M
CBAY
47
DELISTED
Cymabay Therapeutics
CBAY
$3.19M 0.86%
239,827
+52,500
+28% +$558K
ICLR icon
48
Icon
ICLR
$12.6B
$3.07M 0.83%
22,471
+905
+4% +$123K
HUM icon
49
Humana
HUM
$43.7B
$2.88M 0.78%
10,817
-5,500
-34% -$1.58M
HROW icon
50
Harrow
HROW
$1.45B
$2.69M 0.73%
541,114
+205,750
+61% +$1.24M
1
2
3 4

Similar funds

GUB
Golden Unicorn BVI Road Town $697M AUM 55.92% 1-Year Est. Return
KLI
Kelman-Lazarov Inc Memphis, Tennessee $698M AUM 14.07% 1-Year Est. Return
JA
JLB & Associates Plymouth, Michigan $696M AUM 17.86% 1-Year Est. Return
WIC
Wilkins Investment Counsel Boston, Massachusetts $698M AUM 17.36% 1-Year Est. Return
AAM
Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return
TCM
Tensile Capital Management Larkspur, California $698M AUM 2.4% 1-Year Est. Return
CA
Calton & Associates Tampa, Florida $696M AUM 18.3% 1-Year Est. Return
SAM
Silverback Asset Management Chapel Hill, North Carolina $699M AUM 72.42% 1-Year Est. Return

Sio Capital Management's Q1 2019 Portfolio in Review

As of Q1 2019, Sio Capital Management held 91 positions worth $370M, up 35% from $275M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Sio Capital Management deployed $73.9M of net new capital in Q1 2019, opening 23 new positions and adding to 27 existing holdings. Its largest new stake was Biogen: 78,596 shares worth $18.6M.

By sector, the portfolio is most concentrated in Healthcare at 81% of assets, down from 91% a quarter earlier, followed by Industrials.

On the sell side, the largest reduction was Alnylam Pharmaceuticals, an estimated $6.31M trimmed.

  • Sio Capital Management's largest Q1 2019 buy was Biogen: 78,596 shares worth $18.6M.
  • Sio Capital Management added most to CVS Health in Q1 2019, an estimated $13.7M increase.
  • Sio Capital Management's biggest Q1 2019 reduction was Alnylam Pharmaceuticals, cutting an estimated $6.31M.
  • Sio Capital Management fully exited Cencora in Q1 2019, selling an estimated $9.96M.
  • Sio Capital Management's ten largest holdings make up 36% of its $370M portfolio in Q1 2019.
  • Sio Capital Management opened 23 new positions and closed 22 in Q1 2019.
  • Sio Capital Management's portfolio value rose 35% quarter-over-quarter to $370M.

Based on Sio Capital Management's 13F filing for Q1 2019, filed 15 May 2019.